SCHEMBL3673984

SCHEMBL3673984

CCOC(=O)NNC(=O)c1cccc(N)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.56
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
GAA P10253 1/20 0.45
ELANE P08246 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 2/20 0.44
POLB P06746 2/20 0.44
MITF O75030 1/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
KDM4C Q9H3R0 1/20 0.43
RAB9A P51151 1/20 0.43
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
ADRB3 P13945 2/20 0.43
KAT6A Q92794 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20557435 0.82 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1GAANPC1POLB
SCHEMBL9921285 0.82 SMN1; SMN2 (0.59) SMN1; SMN2KDM4EALDH1A1NPSR1HSD17B10
SCHEMBL4690962 0.79 HDAC3 (0.61) SMN1; SMN2ALDH1A1GAANPSR1POLB
SCHEMBL13249005 0.79 KDM4E (0.50) SMN1; SMN2KDM4EALDH1A1GAAELANE
SCHEMBL8616315 0.78 SMN1; SMN2 (0.56) SMN1; SMN2KDM4EALDH1A1GAANPC1
SCHEMBL7867966 0.78 ALDH1A1 (0.54) SMN1; SMN2KDM4EALDH1A1NPSR1HSD17B10
SCHEMBL29465556 0.78 LMNA (0.62) SMN1; SMN2ALDH1A1ELANENPC1LMNA
SCHEMBL133366 0.78 LMNA (0.62) SMN1; SMN2ALDH1A1ELANENPC1LMNA
SCHEMBL27542687 0.77 SMN1; SMN2 (0.54) SMN1; SMN2KDM4EALDH1A1NPSR1HSD17B10
Methane SCHEMBL15286491 0.76 LMNA (0.61) SMN1; SMN2ALDH1A1ELANENPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137314-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
US-20100099692-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099692-A1 HARMFUL ORGANISM CONTROL COMPOSITION UQCRC1, UQCRC2, Q6ZSR9 SMN1; SMN2 3015/4885KDM4E 2026/4885ALDH1A1 280/4885
US-20100137314-A1 HARMFUL ORGANISM CONTROL COMPOSITION UQCRC2, UQCRC1, UQCRB SMN1; SMN2 3145/4885KDM4E 2615/4885ALDH1A1 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.